Clinical Trial Update: Tolerability, Safety and Immunogenicity Trial of the Flu-M Tetra Vaccine in Children [Phase 3]

View source ↗

Summary

Phase 3 trial assessing tolerability, safety, and immunogenicity of the Flu-M Tetra vaccine in children; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza Viral Infections

Drugs mentioned

• Flu-M Tetra vaccine

Snippet

Sponsor: St. Petersburg Research Institute of Vaccines and Sera | Conditions: Influenza, Influenza, Human | Phase 3 | Status: UNKNOWN